Investor buzz around cannabis stocks with new treatments
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent. Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the ... Read More